Cilostazol – antiplatelet drug with great prospects
ReadCilostazol: many years of experience and new research
ReadConservative therapy of diseases of the peripheral arteries of the lower extremities European Society of Vascular Surgery (ESVS) 2024 (ZU)
Gudz I.M. Clinical management of patients with
ReadI.I. Kobza, T.B. Rudyk, T.I. Kobza Modern antiplatelet therapy in patients with cardiovascular diseases
ReadI.M.Gudz Special role of cilostazol on the treatment of patients with manifestation of claudication intermittent acording to the recommendations evidence-based medicine
ReadMohammed A. Abosheasha, Afnan H. El-Gowily, Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 Mpro and spike protein: Drug repurposing approach
ReadOlena Voloshyna Modern recommendations on diagnostics and treatment of lower extremity arteries diseases in the family doctors practice (review of the literature)
ReadSecondary stroke prevention: what do we know about cilostazol?
ReadV. Subbotin Ñomplex correction of platelet aggregation activity as the prevention of critical ischemia progression in patients with diabetic foot
ReadV.A. Prasol, K.V. Miasoiedov, V.V. Shaprynskyi, ADVISABILITY OF USING CILOSTAZOL IN PATIENTS WITH CHRONIC LIMB-THREATENING ISCHEMIA
Read